Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology

MLA

Kerschbaumer, Andreas, et al. “Efficacy Outcomes in Phase 2 and Phase 3 Randomized Controlled Trials in Rheumatology.” Nature Medicine, vol. 26, no. 6, June 2020, p. 974. EBSCOhost, https://doi.org/10.1038/s41591-020-0833-4.

APA

Kerschbaumer, A., Smolen, J. S., Herkner, H., Stefanova, T., Chwala, E., & Aletaha, D. (2020). Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology. Nature Medicine, 26(6), 974. https://doi.org/10.1038/s41591-020-0833-4

Chicago

Kerschbaumer, Andreas, Josef S. Smolen, Harald Herkner, Tijen Stefanova, Eva Chwala, and Daniel Aletaha. 2020. “Efficacy Outcomes in Phase 2 and Phase 3 Randomized Controlled Trials in Rheumatology.” Nature Medicine 26 (6): 974. doi:10.1038/s41591-020-0833-4.